• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    New PPO Dental Plans More Competitive Against HMOs

    6/11/25 10:07:00 AM ET
    $CI
    $HUM
    $MET
    Medical Specialities
    Health Care
    Medical Specialities
    Health Care
    Get the next $CI alert in real time by email

    LOS ANGELES, June 11, 2025 /PRNewswire/ -- DentalInsurance.com, the leader in dental insurance comparison shopping, has broadened its inventory of PPO dental plans offering high maximum benefits. A maximum benefit is the annual cap on insurance company spending toward a consumer's covered dental care. PPO plans have a maximum benefit limit while HMO dental insurance doesn't. PPOs, however, have much wider dentist networks than most competing HMO plans. This helps consumers receive quality dental care from a trusted preferred dentist. By adding high maximum benefits, a new generation of PPO dental plans have become an even more attractive option for consumers.

    DentalInsurance.com logo, helping people find the coverage they need at an affordable price. (PRNewsfoto/DentalInsurance.com)

    Traditionally PPO plans have maximum benefits around $2,000 annually. If the cost of covered dental care exceeds that amount, it is the responsibility of the enrollee to pay. With this new generation of PPO plans, maximum benefit increases range from 25 percent to 400 percent higher ($2,500 to $10,000 in total).

    "High maximum benefit PPO plans have become an essential part of our business," commented DentalInsurance.com President Avery Smith. "Many consumers aren't satisfied with the wider dentist network of a PPO unless the coverage comes with solid protection against high out-of-pocket costs."

    DentalInsurance.com offers a variety of high maximum dental plans from top brands such as MetLife (NYSE:MET), Cigna Cigna (NYSE:CI), Humana Humana (NYSE:HUM), Guardian, and Delta Dental:

    • NCD Complete by MetLife ($10,000 maximum benefit)
    • Humana Extend 5000 ($5,000 maximum benefit)
    • NCD Elite 5000 by MetLife ($5,000 maximum benefit)
    • Delta Dental Immediate Coverage Plan ($3,000 maximum benefit)
    • Guardian Advantage Premier ($3,000 maximum benefit)
    • Cigna Dental Vision Hearing 3500 ($2,500 maximum benefit on dental work with separate limits on additional hearing and vision benefits)
    • Delta Dental Dental for Everyone Platinum ($2,500 maximum benefit)
    • Anthem BlueCross Essential Choice Incentive ($2,500 maximum benefit)

    Consumers shopping for high maximums should always read insurance conditions to see if a maximum excludes any service or is lower on a particular category of care (e.g. braces). For more detailed on dental plans with high maximum benefits, see Dental Plans with the Best Maximum Benefits.

    Launched in 2001 by Mark Kelsey, DentalInsurance.com is the pioneer of the online dental insurance marketplaces. DentalInsurance.com is headquartered in Los Angeles, California, and boasts an A+ rating from the Better Business Bureau and a 4.8 stars out of 5 on TrustPilot.

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/new-ppo-dental-plans-more-competitive-against-hmos-302478365.html

    SOURCE DentalInsurance.com

    Get the next $CI alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CI
    $HUM
    $MET

    CompanyDatePrice TargetRatingAnalyst
    Humana Inc.
    $HUM
    5/1/2025$315.00Mkt Perform → Outperform
    Raymond James
    The Cigna Group
    $CI
    2/6/2025$323.00Outperform → Mkt Perform
    Bernstein
    MetLife Inc.
    $MET
    1/23/2025$97.00Market Perform
    BMO Capital Markets
    Humana Inc.
    $HUM
    11/6/2024$247.00 → $308.00Underperform → Neutral
    BofA Securities
    Humana Inc.
    $HUM
    10/11/2024Sector Weight
    KeyBanc Capital Markets
    MetLife Inc.
    $MET
    10/9/2024$97.00Buy
    TD Cowen
    Humana Inc.
    $HUM
    10/8/2024$308.00Mkt Perform → Outperform
    Bernstein
    Humana Inc.
    $HUM
    10/7/2024$402.00 → $261.00Buy → Hold
    TD Cowen
    More analyst ratings

    $CI
    $HUM
    $MET
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SVP, Chief Accting Off & Cont. Felter John-Paul W. converted options into 211 units of Humana Common and covered exercise/tax liability with 97 units of Humana Common, increasing direct ownership by 6% to 1,881 units (SEC Form 4)

    4 - HUMANA INC (0000049071) (Issuer)

    8/5/25 1:22:18 PM ET
    $HUM
    Medical Specialities
    Health Care

    SEC Form 4 filed by Director Hilzinger Kurt J

    4 - HUMANA INC (0000049071) (Issuer)

    7/2/25 4:18:17 PM ET
    $HUM
    Medical Specialities
    Health Care

    SEC Form 4 filed by Director Smith Gordon

    4 - HUMANA INC (0000049071) (Issuer)

    7/2/25 2:21:21 PM ET
    $HUM
    Medical Specialities
    Health Care

    $CI
    $HUM
    $MET
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    MetLife Declares Third Quarter 2025 Preferred Stock Dividends

    MetLife, Inc. (NYSE:MET) today announced that it has declared the following preferred stock dividends: Quarterly dividend of $0.35263005 per share on the company's floating rate non-cumulative preferred stock, Series A, with a liquidation preference of $25 per share (NYSE:MET). Semi-annual dividend of $29.375 per share on the company's 5.875% fixed-to-floating rate non-cumulative preferred stock, Series D, with a liquidation preference of $1,000 per share. Quarterly dividend of $351.5625 per share on the company's 5.625% non-cumulative preferred stock, Series E, with a liquidation preference of $25,000 per share, represented by depositary shares each representing 1/1,000th interest

    8/15/25 4:15:00 PM ET
    $MET
    Life Insurance
    Finance

    MetLife CEO Michel Khalaf and CFO John McCallion to Speak at the 2025 Keefe, Bruyette & Woods Insurance Conference

    MetLife, Inc. (NYSE:MET) today announced that Michel Khalaf, president and chief executive officer, and John McCallion, executive vice president and chief financial officer, and head of MetLife Investment Management, will participate in a fireside chat at the 2025 Keefe, Bruyette & Woods Annual Insurance Conference on Wednesday, Sept. 3, 2025, from 10:05 a.m. to 10:45 a.m. (ET). A live audio webcast of the presentation will be available at https://event.summitcast.com/view/K8Qj6Ho6wvLLfFK2h5DE7w/n8bgBuwQnmybd6vjVT2Jmi. Those who want to listen should go to the website at least 15 minutes prior to the presentation to download and install any necessary software. A replay of the presentation

    8/13/25 4:15:00 PM ET
    $MET
    Life Insurance
    Finance

    Humana and DrFirst Partner on Innovation to Fill Gaps in Care, Improve Outcomes for Patients with Diabetes and Other Chronic Conditions

    Program Designed to Increase Use of Recommended Medication Therapy by Connecting with Providers in Workflow LOUISVILLE, Ky. and ARLINGTON, Va., Aug. 13, 2025 /PRNewswire/ -- Humana Inc. (NYSE:HUM), one of the nation's leading health and well-being companies, and health technology pioneer DrFirst today announced the launch of a program designed to close gaps in care for patients with chronic health conditions like diabetes and cardiovascular disease while helping health care providers take timely, informed action. The first phase of this novel program aims to increase the use of statin therapy among eligible patients, aligning with a key quality metric from the Centers for Medicare & Medicaid

    8/13/25 8:04:00 AM ET
    $HUM
    Medical Specialities
    Health Care

    $CI
    $HUM
    $MET
    SEC Filings

    View All

    MetLife Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - METLIFE INC (0001099219) (Filer)

    8/15/25 4:21:47 PM ET
    $MET
    Life Insurance
    Finance

    SEC Form 144 filed by The Cigna Group

    144 - Cigna Group (0001739940) (Subject)

    8/15/25 3:54:00 PM ET
    $CI
    Medical Specialities
    Health Care

    SEC Form 13F-HR filed by MetLife Inc.

    13F-HR - METLIFE INC (0001099219) (Filer)

    8/13/25 4:11:16 PM ET
    $MET
    Life Insurance
    Finance

    $CI
    $HUM
    $MET
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Humana upgraded by Raymond James with a new price target

    Raymond James upgraded Humana from Mkt Perform to Outperform and set a new price target of $315.00

    5/1/25 7:42:13 AM ET
    $HUM
    Medical Specialities
    Health Care

    The Cigna Group downgraded by Bernstein with a new price target

    Bernstein downgraded The Cigna Group from Outperform to Mkt Perform and set a new price target of $323.00

    2/6/25 7:05:01 AM ET
    $CI
    Medical Specialities
    Health Care

    BMO Capital Markets initiated coverage on MetLife with a new price target

    BMO Capital Markets initiated coverage of MetLife with a rating of Market Perform and set a new price target of $97.00

    1/23/25 7:50:09 AM ET
    $MET
    Life Insurance
    Finance

    $CI
    $HUM
    $MET
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President & CEO Rechtin James A. bought $1,496,984 worth of Humana Common (6,530 units at $229.25) (SEC Form 4)

    4 - HUMANA INC (0000049071) (Issuer)

    5/16/25 4:48:13 PM ET
    $HUM
    Medical Specialities
    Health Care

    Mesquita Jorge S. bought $200,066 worth of Humana Common (545 units at $367.09) (SEC Form 4)

    4 - HUMANA INC (0000049071) (Issuer)

    2/21/24 10:37:23 AM ET
    $HUM
    Medical Specialities
    Health Care

    Johnson Jeh C. bought $879 worth of shares (17 units at $51.69) and was granted 19 shares, increasing direct ownership by 1% to 2,545 units (SEC Form 4)

    4 - METLIFE INC (0001099219) (Issuer)

    12/18/23 5:20:05 PM ET
    $MET
    Life Insurance
    Finance

    $CI
    $HUM
    $MET
    Leadership Updates

    Live Leadership Updates

    View All

    National Mall of Pickleball Returns for Third Year with Expanded Footprint and New, Central Location

    The National Mall of Pickleball will celebrate America's most accessible sport and the game that serves all in the heart of the National Mall this September The Trust for the National Mall, Humana (NYSE:HUM), and the Humana Foundation announced today that the highly-anticipated National Mall of Pickleball is returning to America's Front Yard, the National Mall, for a third year. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250625316935/en/ From Friday, September 19 through Sunday, September 21, 2025, the general public can experience a weekend full of pickleball programming, activities, and community with captivating views o

    6/25/25 9:00:00 AM ET
    $HUM
    Medical Specialities
    Health Care

    Humana Launches "Invite" Campaign to Inspire Active Aging Through Pickleball and Community Connection

    Humana Inc. (NYSE:HUM), a leading health and well-being company, is expanding its commitment to senior wellness with the launch of Invite, a new campaign designed to encourage older adults of all fitness levels to stay active, connected and engaged – starting with the fastest-growing sport in America: pickleball. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250618737488/en/As part of Humana's new "Invite" campaign, the health and wellness company debuted a television spot featuring senior pickleball athletes extending an open invitation to others to join the fun, stay social, and support their physical and mental well-being. A

    6/18/25 8:30:00 AM ET
    $HUM
    Medical Specialities
    Health Care

    The Cigna Group Announces Appointment of Michael J. Hennigan to Board of Directors

    BLOOMFIELD, Conn., June 2, 2025 /PRNewswire/ -- Global health company The Cigna Group (NYSE:CI) announced today that Michael J. Hennigan has been appointed to the organization's Board of Directors. His appointment is effective June 2. Mr. Hennigan is the Executive Chairman of Marathon Petroleum Corporation (MPC), an integrated downstream energy company, and MPLX, a diversified master limited partnership formed by MPC. He joined the company in 2017 and previously held the roles of Chief Executive Officer of MPC and Chairman, President and Chief Executive Officer of MPLX. Prior

    6/2/25 4:30:00 PM ET
    $CI
    Medical Specialities
    Health Care

    $CI
    $HUM
    $MET
    Financials

    Live finance-specific insights

    View All

    MetLife Declares Third Quarter 2025 Preferred Stock Dividends

    MetLife, Inc. (NYSE:MET) today announced that it has declared the following preferred stock dividends: Quarterly dividend of $0.35263005 per share on the company's floating rate non-cumulative preferred stock, Series A, with a liquidation preference of $25 per share (NYSE:MET). Semi-annual dividend of $29.375 per share on the company's 5.875% fixed-to-floating rate non-cumulative preferred stock, Series D, with a liquidation preference of $1,000 per share. Quarterly dividend of $351.5625 per share on the company's 5.625% non-cumulative preferred stock, Series E, with a liquidation preference of $25,000 per share, represented by depositary shares each representing 1/1,000th interest

    8/15/25 4:15:00 PM ET
    $MET
    Life Insurance
    Finance

    MetLife Announces 2Q 2025 Results

    MetLife, Inc. (NYSE:MET) today announced its second quarter 2025 results.   Earnings       Return     Per Share       on Equity (ROE)     2Q 2025       2Q 2025                         Net Income $1.03 ROE 11.7%                       Adjusted Earnings $2.02 Adjusted ROE 14.6% Net income was $698 million. Adjusted earnings declined to $1.4 billion, due to less favorable underwriting and lower investment margins, partially offset by volume growth and favorable expense margins. Premiums, fees and other revenues (PFOs) were $12.7 billion. Adjusted

    8/6/25 4:15:00 PM ET
    $MET
    Life Insurance
    Finance

    MetLife CFO John McCallion Provides Second Quarter 2025 Financial Update Video

    MetLife, Inc. (NYSE:MET) today announced that John McCallion, executive vice president and chief financial officer, and head of MetLife Investment Management, has provided a second quarter 2025 financial update video. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250806874930/en/ The video can be viewed on the company's website at https://www.metlife.com/about-us/newsroom/#video. About MetLife MetLife, Inc. (NYSE:MET), through its subsidiaries and affiliates ("MetLife"), is one of the world's leading financial services companies, providing insurance, annuities, employee benefits and asset management to help individual and i

    8/6/25 4:15:00 PM ET
    $MET
    Life Insurance
    Finance

    $CI
    $HUM
    $MET
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by The Cigna Group

    SC 13G - Cigna Group (0001739940) (Subject)

    11/12/24 9:55:14 AM ET
    $CI
    Medical Specialities
    Health Care

    Amendment: SEC Form SC 13D/A filed by MetLife Inc.

    SC 13D/A - METLIFE INC (0001099219) (Subject)

    11/1/24 5:05:26 PM ET
    $MET
    Life Insurance
    Finance

    Amendment: SEC Form SC 13D/A filed by MetLife Inc.

    SC 13D/A - METLIFE INC (0001099219) (Subject)

    8/1/24 4:38:49 PM ET
    $MET
    Life Insurance
    Finance